Growth hormone has anabolic effects in glucocorticosteroid-dependent children with inflammatory bowel disease: A pilot study

Metabolism: Clinical and Experimental

Volumn 51, Issue 1, 2002, Pages 127-135

  Mauras, Nelly ^a,b,c   George, Donald ^a,b,c   Evans, Jonathan ^a,b,c   Milov, David ^a,b,c   Abrams, Steven ^a,b,c   Rini, Annie ^a,b,c   Welch, Susan ^a,b,c   Haymond, Morey W ^a,b,c  

^a NEMOURS CHILDREN S CLINIC   (United States)

^b NEMOURS CHILDREN S HOSPITAL   (United States)

^c Children's Nutritional Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; CALCIUM ION; FAT; GLUCOCORTICOID; GLUCOSE; GROWTH FACTOR; HEMOGLOBIN A1C; HUMAN GROWTH HORMONE; HYOSCYAMINE; INSULIN; IRON; ISOTOPE; LEUCINE; MERCAPTOPURINE; MESALAZINE; OLSALAZINE; PREDNISONE; RANITIDINE; RECOMBINANT GROWTH HORMONE; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; VITAMIN;

ARTICLE; BODY COMPOSITION; BODY GROWTH; BODY MASS; BONE METABOLISM; BONE TURNOVER; CALCIUM ABSORPTION; CALCIUM TRANSPORT; CARBOHYDRATE TOLERANCE; CATABOLISM; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONCENTRATION (PARAMETERS); CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROHN DISEASE; DIET RESTRICTION; DISEASE ASSOCIATION; DOSE RESPONSE; DRUG ANTAGONISM; DRUG DEPENDENCE; DRUG EFFECT; DRUG EXPOSURE; DRUG SAFETY; DUAL ENERGY X RAY ABSORPTIOMETRY; ENERGY EXPENDITURE; ENTERITIS; FEMALE; GLUCOSE OXIDATION; GROWTH HORMONE RELEASE; GROWTH RATE; GROWTH RETARDATION; HUMAN; LINEAR SYSTEM; MALE; METABOLIC DISORDER; OSSIFICATION; PILOT STUDY; POSTPRANDIAL STATE; PRIORITY JOURNAL; PROTEIN METABOLISM; TRANSPORT KINETICS;

EID: 0036145802     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1053/meta.2002.28972     Document Type: Article

References (63)

1. Glucocorticosteroids increase leucine oxidation and impair leucine balance in humans
2. General aspects of the regulation of protein metabolism by diet and by hormones
3. Thigh muscle mass and function in patients treated with glucocorticoids
4. Overestimation of renal function glucocorticosteroid treated patients
5. Altered body fat distribution in patients with glucocorticoid treatment and in patients on long term dialysis
6. Differential effect of glucocorticoids on calcium absorption and bone mass
7. Reversibility of exogenous corticosteroid-induced bone loss
8. The course of biochemical parameters of bone turnover during treatment with corticosteroids
9. Bone loss in response to long term glucocorticoid therapy
10. Effects of glucocorticoids on carbohydrate metabolism
11. The influence of acute physiological increments of cortisol on fuel metabolism and insulin binding on monocytes in normal humans
12. Cortisol induced insulin resistance in man: Impaired suppression of glucose production and stimulation of glucose utilization due to a preceptor defect of insulin action
13. Effects of prolonged cortisone therapy on the statural growth, skeletal maturation and metabolic status of children
14. Glucocorticoids: Potent inhibitors and stimulators of growth hormone secretion
15. Effects of dexamethasone on GHRH, arginine and dopaminergic stimulated GH secretion, and total plasma IGF-I concentrations in normal male volunteers
16. Dexamethasone impairs growth hormone (GH)-stimulated growth by suppression of local insulin-like growth factor (IGF)-I production and expression of GH- and IGF-I-receptor in cultured rat chondrocytes
17. Growth hormone, burns and tissue healing
18. The use of growth hormone in severely ill patients
19. Treatment with growth hormone conserves lean body mass during dietary restriction in obese volunteers
20. Treatment of obese, diet-restricted subjects with growth hormone for 11 weeks: Effects of anabolism, lipolysis and body composition
21. Growth hormone together with glutamine-containing total parenteral nutrition maintains muscle glutamine levels and results in a less negative nitrogen balance after surgical trauma
22. Human growth hormone prevents the protein catabolic side effects of prednisone in humans
23. rhIGF-I enhances whole body protein anabolism and significantly diminishes the protein-catabolic effects of prednisone in humans, without a diabetogenic effect
24. IGF and bone
25. Regulatory effects of IGF-I and II on bone collagen synthesis in rat calvarial cultures
26. IGF-I increases trabecular bone formation and osteoblastic cell proliferation in unloaded rats
27. In vivo actions of IGF-I on bone formation and resorption in rats
28. IGF-I enhances the formation of type I collagen in hydrocortisone-treated osteoblasts
29. Development and validation of a pediatric Crohn's disease activity index
30. Heated dorsal hand vein sampling for metabolic studies: A reappraisal
31. Use of t-butyldimethyl silyation in gas chromatographic mass spectrometric analysis of physiologic compounds found in plasma using electron impact ionization
32. Changes in calcium kinetics associated with menarche
33. Differences in calcium absorption and kinetics between black and white girls age 5-16 years
34. Use of reciprocal pool specific activities to model leucine metabolism in humans
35. Plasma reciprocal pool specific activity predicts that of intracellular free leucine for protein synthesis
36. Stable isotopic measurement of endogenous fecal calcium excretion in children
37. The theoretical bases of indirect calorimtery. A review
38. Growth hormone therapy in adults and children
39. Low-dose rhGH increases body weight and lean body mass in patients with short bowel syndrome
40. Effects of glucocorticoids on energy metabolism and food intake in humans
41. Corticoid-induced growth-hormone (GH) secretion in GH-deficient and normal children
42. The role of glucocorticoids in the regulation of growth hormone secretion - Mechanisms and clinical significance
43. Glucocorticoid-induced changes in the quantity and secretory capacity of individual rat somatotropes
44. Glucocorticoids may inhibit growth hormone release by enhancing beta-adrenergic responsiveness in hypothalamic somatostatin neurons
45. Glucocorticoids and growth problems
46. Cortisol inhibits the synthesis of IGF-I in skeletal cells
47. Dexamethasone acts locally to inhibit longitudinal bone growth in rabbits
48. Growth failure in children with inflammatory bowel disease: A prospective study
49. Treatment of glucocorticoid-induced growth suppression with growth hormone
50. Effect of growth hormone treatment on the adult height of children with chronic renal failure. German Study Group of Growth Hormone Treatment in Chronic Renal Failure
51. Effect of growth hormone treatment in children with cystic fibrosis: The National Cooperative Growth Study Experience
52. Combined recombinant human growth hormone and recombinant human insulin-like growth factor I: Lack of synergy on whole body protein anabolism in normally fed subjects
53. IGF-I and GH treatment in GH deficient humans: Differential effects on protein, glucose, lipid and calcium metabolism
54. Mineral metabolism in children with dermatomyositis
55. Growth hormone increases cortical and cancellous bone mass in young growing rats with glucocorticoid-induced osteopenia
56. M bone mineral content and anthropometric variables in men: A cross-sectional study in 324 normal subjects
57. Bone mineral acquisition during adolescence and early adulthood: A study in 574 healthy females 10-24 years of age
58. Intermittent etidronate therapy to prevent corticosteroid-induced osteoporosis
59. Risk of persistent growth impairment after alternate day prednisone treatment in children with cystic fibrosis
60. Effects of growth hormone in short children after renal transplantation. French Society of Pediatric Neprhology
61. Beneficial effects of one year growth hormone administration to children with juvenile chronic arthritis on chronic steroid therapy. I. Effects on growth velocity and body composition
62. A preliminary study of growth hormone therapy for Crohn's disease